In Vitro Susceptibilities of 180 Clinical Isolates of Haemophilus Influenzae to Ampicillin, Amoxycillin/Clavulanate, Cefaclor, Cefuroxime, Cefotaxime, Clarithromycin, and Azithromycin

References

• Mathics AW Jr. Penicillins in the treatment of bacterial meningitis. J Roy Coll Phycns Lond. 1972; 6: 139–46.
   Google Scholar
• Thomas WJ, McReynolds JW, Mock CR, Bailey DW. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet. 1974; i: 313.
   Google Scholar
• Turk DC. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet. 1974; i: 453.
   Google Scholar
• Clymo AB, Harper IA. Ampicillin-resistant Haemophilus influenzae meningitis. Lancet. 1974; i: 453–4.
   Google Scholar
• Price E, Boswell PA. Ampicillin-resistant Haemophilus influenzae. Lancet. 1974; i; 936–7.
   Google Scholar
• Gunn BA, Woodall JB, Jones JF, Thornsbcrry C. Ampicillin-resistant Haemophilus influenzae-Lancet. 1974; ii: 845.
   Google Scholar
• Khan W, Ross S, Rodriguez W, Controni G, Saz AK. Haemophilus influenzae type b resistant to ampicillin. JAMA. 1974; 229: 298–301.
   Google Scholar
• Eickhoff TC, Ehret JM, Dixie Baines R. Characterization of an ampicillin-resistant Haemophilus influenzae type b. Antimicrob Agents Chemother. 1976; 9: 889–92.
   Google Scholar
• Medeiros AA, O’Brien TF. Ampicillin-resistant Haemophilus influenzae type b possessing a TEM-typc, p-lactamase but little permeability barrier to ampicillin. Lancet. 1975; i: 716–9.
   Google Scholar
• Markowitz SM. Isolation of an ampicillin-resistant, non p-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother. 1980; 17: 80–3.
   Google Scholar
• Fuchs PC, Barry AL. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxycillin, and amoxycillin-clavulanic acid. J Clin Microbiol. 1994; 32: 2846–50.
   Google Scholar
• Barry AL, Fuchs PC, Pfaller MA. Susceptibilities of P-lactamase-producing and nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefiximc, cefotaxime, and amoxycillin-clavulanic acid. Antimicrob Agents Chemother. 1993; 37: 14–8.
   Google Scholar
• Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J. 1994; 13: S9–S14.
   Google Scholar
• Goldstein FW, Acar JF. Epidemiology of antibiotic resistance in Haemophilus influenzae. Microb Drug Resistance. 1995; 1: 131–5.
   Google Scholar
• Kilian M. Haemophilus. In: Balows A, Ed. Manual of Clinical Microbiology. Fifth Edition. Washington, D.C.: ASM. 1991:463–70.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. NCCLS Document M7-A3, Vol. 13 No. 25, Villanova PA, 1993.
   Google Scholar
• Kayser FH, Morenzoni G, Santanam P. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur J Clin Microbiol Infect Dis. 1990; 9: 810–7.
   Google Scholar
• Jordens JZ, Slack MPE. Haemophilus influenzae: then and now. Eur J Clin Microbiol Infect Dis. 1995; 14: 935’48.
   Google Scholar
• Ducoffre G. Surveillance des maladies infectieuses par un rdseau de laboratoires de microbiologic, 1994 + rdtrospective 1983–1993. Rapport de l’lnstitut d’Hygifene et d’Epid£miologie. D6cembre 1995: 28–30.
   Google Scholar
• Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother. 1994; 38: 2419–25.
   Google Scholar
• Barry AL, Fuchs PC. Susceptibility of bacterial respiratory tract pathogens to amoxycillin and amoxycillin-clavulanic acid. Eur J Clin Microbiol Infect Dis. 1994; 13:442–4.
   Google Scholar
• Scriver SR. Walmsley SL, Kau CL, et al. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterisation of their p-lactamases. Antimicrob Agents Chemother. 1994; 38: 1678–80.
   Google Scholar
• Dabernat H, Seguy M, Delmas C. Situation 1993 de la resistance aux antibiotiques chez Haemophilus influenzae en France (bilan du Centre National de Rdterence pour//, influenzae). Med Mai Infect. 1994; 24: 1244–47.
   Google Scholar
• Delmde M, Glupczynski Y, Gordts B, Van Landuyt H, Van Noyen R. Amoxycillin/clavulanate and Haemophilus influenzae. Acta Clin Belg. 1994;49:311–2.
   Google Scholar
• Verbist L, Dhoore F. In vitro susceptibility of recently isolated respiratory tract pathogens to minocycline and comparable antibiotics. A multicentre study. Acta Clin Belg. 1994; 49: 268–73.
   Google Scholar
• Hussey G, Hitchcock J, Hanslo D, et al. Serotypes and antimicrobial susceptibility of Haemophilus influenzae. J Antimicrob Chemother. 1994; 34: 1031–36.
   Google Scholar
• Fass RJ. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. Antimicrob Agents Chemother. 1993; 37: 208086.
   Google Scholar
• Bairy AL, Fuchs PC, Brown SD. Relative potenlies of azithromycin, clarithromycin, and five other orally administered antibiotics. J Antimicrob Chemother. 1995; 35: 552–5.
   Google Scholar
• Peters DH, Clissold SP. Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs. 1992; 44: 117–64.
   Google Scholar
• Peters DH, Friedel AH, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1992;44:750–99.
   Google Scholar